< Back to search
Filter
1

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05657873

Phase2, Recruiting

Idylla EGFR Lung Trial

for
Lung Cancer, Technology, Oncology
Location: Orlando FL
Sponsor: Anthony Magliocco

Sex: All

Age: 18+

Code: NCT04962191

Recruiting

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Halifax, Montreal, Toronto, Calgary, Vancouver
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT06960291

Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

for
Extensive-Stage Small Cell Lung Cancer
Location: Durham NC, Roanoke VA, Orange City FL, Fort Myers FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06646276

Phase3, Recruiting

Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

for
Non Small Cell Lung Cancer Stage
Location: Lee's Summit MO, Kansas City KS, Kansas City MO,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT04992780

Phase2, Recruiting

Interested in new lung cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: Fairfax VA, Irving TX, Austin TX, San Antonio TX
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT06090266

Phase1, Phase2, Recruiting
New

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

for
Pulmonary Disease, Chronic Obstructive
Location: Doral FL, Lake Charles LA
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07780669

Phase3, Recruiting
New

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Durham NC, Indianapolis IN, North Richland Hills TX
Sponsor: Sanofi

Sex: All

Age: 40+

Code: NCT07612878

Recruiting
New

The SEQUENCE Trial

for
Pulmonary Nodules
Location: Baltimore MD, Chapel Hill NC, Ann Arbor MI, Chicago IL,
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06676956

Recruiting
New

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Naples FL, Bend OR
Sponsor: Insmed Incorporated

Sex: All

Age: 18+

Code: NCT07234032

Phase3, Recruiting
New

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

for
Pulmonary Hypertension, Interstitial Lung Disease,
Location: Kissimmee FL, Louisville KY, Bend OR
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07816185

Phase3, Recruiting
New

Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)

for
Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 21+

Code: NCT07527117

Recruiting
New

HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

for
Pulmonary Hypertension,
Location: Greenville SC
Sponsor: 35Pharma Inc

Sex: All

Age: 18+

Code: NCT07123779

Phase1, Phase2, Recruiting
New

A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

for
Pulmonary Arterial Hypertension
Location: Providence RI, Tampa FL
Sponsor: 35Pharma Inc

Sex: All

Age: 18+

Code: NCT07143448

Phase1, Phase2, Recruiting

Biological Effects of Quercetin in COPD Phase II

for
Chronic Obstructive Pulmonary Disease, Emphysema,
Location: Philadelphia PA
Sponsor: Temple University

Sex: All

Age: 40 - 70+

Code: NCT06003270

Phase2, Recruiting

Chronic Thromboembolic Disease Registry

for
Chronic Thromboembolic Pulmonary Hypertension,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05843500

Recruiting

Role of Genetic Factors in the Development of Lung Disease

for
Cystic Fibrosis, Pulmonary Fibrosis, Tuberous Sclerosis, Asthma,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 2 - 70+

Code: NCT00001532

Recruiting

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

for
Hypertension, Pulmonary, Pulmonary Thromboembolisms
Location: Montreal
Sponsor: Jewish General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05719415

Recruiting

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 40 - 70+

Code: NCT05572632

Recruiting

A National Registry For Pulmonary Alveolar Proteinosis

for
Pulmonary Alveolar Proteinosis
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02461615

Recruiting